276 related articles for article (PubMed ID: 24087794)
1. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
Berthon A; Drelon C; Ragazzon B; Boulkroun S; Tissier F; Amar L; Samson-Couterie B; Zennaro MC; Plouin PF; Skah S; Plateroti M; Lefèbvre H; Sahut-Barnola I; Batisse-Lignier M; Assié G; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P
Hum Mol Genet; 2014 Feb; 23(4):889-905. PubMed ID: 24087794
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
Chang HW; Chu TS; Huang HY; Chueh SC; Wu VC; Chen YM; Hsieh BS; Wu KD
J Clin Endocrinol Metab; 2007 May; 92(5):1863-70. PubMed ID: 17299068
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in CTNNB1 in aldosterone producing adenomas.
Åkerström T; Maharjan R; Sven Willenberg H; Cupisti K; Ip J; Moser A; Stålberg P; Robinson B; Alexander Iwen K; Dralle H; Walz MK; Lehnert H; Sidhu S; Gomez-Sanchez C; Hellman P; Björklund P
Sci Rep; 2016 Jan; 6():19546. PubMed ID: 26815163
[TBL] [Abstract][Full Text] [Related]
6. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
7. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
Ye P; Mariniello B; Mantero F; Shibata H; Rainey WE
J Endocrinol; 2007 Oct; 195(1):39-48. PubMed ID: 17911395
[TBL] [Abstract][Full Text] [Related]
8. Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.
Pauzi FA; Azizan EA
Front Endocrinol (Lausanne); 2021; 12():631848. PubMed ID: 33763031
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-Producing Adenomas.
Hellman P; Björklund P; Åkerström T
Vitam Horm; 2019; 109():407-431. PubMed ID: 30678866
[TBL] [Abstract][Full Text] [Related]
10. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C
Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways.
Sackmann S; Lichtenauer U; Shapiro I; Reincke M; Beuschlein F
Horm Metab Res; 2011 Feb; 43(2):106-11. PubMed ID: 21249615
[TBL] [Abstract][Full Text] [Related]
13. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
Peng KY; Chang HM; Lin YF; Chan CK; Chang CH; Chueh SJ; Yang SY; Huang KH; Lin YH; Wu VC; Wu KD
J Clin Endocrinol Metab; 2018 Oct; 103(10):3737-3747. PubMed ID: 30085132
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.
Karashima S; Takeda Y; Cheng Y; Yoneda T; Demura M; Kometani M; Ohe M; Mori S; Yagi K; Yamagishi M
Steroids; 2011 Nov; 76(12):1363-6. PubMed ID: 21801737
[TBL] [Abstract][Full Text] [Related]
15. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
16. CTNNB1 Knockdown Inhibits Cell Proliferation and Aldosterone Secretion Through Inhibiting Wnt/β-Catenin Signaling in H295R Cells.
Zhou T; Luo P; Wang L; Yang S; Qin S; Wei Z; Liu J
Technol Cancer Res Treat; 2020; 19():1533033820979685. PubMed ID: 33287648
[TBL] [Abstract][Full Text] [Related]
17. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
Wang B; Zhang G; Ouyang J; Deng X; Shi T; Ma X; Li H; Ju Z; Wang C; Wu Z; Liu S; Zhang X
Urology; 2010 Oct; 76(4):1018.e1-7. PubMed ID: 20708777
[TBL] [Abstract][Full Text] [Related]
18. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism.
Volpe C; Höög A; Ogishima T; Mukai K; Lu M; Thorén M; Hamberger B
J Clin Pathol; 2013 Apr; 66(4):351-4. PubMed ID: 23436930
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
